J&J | Les Charges D'Exploitation



Operating Expenses Changement Date
AbbVie USD 9.71B 96M 2025-06
Abbott USD 9.07B 369M 2025-06
Amgen USD 6.52B 337M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Baxter International USD 2.54B 29M 2025-06
Bayer EUR 10.73B 688M 2025-06
Becton, Dickinson and Co. USD 4.53B 196M 2025-06
Biogen USD 1.79B 326.1M 2025-06
Boston Scientific USD 4.12B 377M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
CONMED USD 304.18M 1.11M 2025-06
Cooper Companies USD 817.5M 34.8M 2025-04
Dexcom USD 944.5M 42.2M 2025-06
Edwards Lifesciences USD 1.1B 83.4M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Globus Medical USD 1.62B 1.12B 2025-06
Hologic USD 762.9M 249.4M 2025-06
Insulet USD 528M 8.3M 2025-06
Integra LifeSciences USD 416.91M 18.3M 2025-06
Intuitive Surgical USD 1.69B 17.8M 2025-06
J&J USD 16.8B 8.54B 2025-06
Medtronic USD 7.06B 430M 2025-07
Merck USD 9.44B 217M 2025-06
Merit Medical Systems USD 335.44M 21.12M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 9.02B 702M 2025-06
Stryker USD 4.85B 175M 2025-06
Tandem Diabetes Care USD 272.54M 82.76M 2025-06
Teva Pharmaceutical Industries USD 3.28B 95M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06
Zimmer Biomet Holdings USD 1.68B 110.7M 2025-06
Zoetis USD 1.44B 35M 2025-06


J&J Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.